EdgarLookup

Spyre Therapeutics, Inc.

SYRE NASDAQ CIK: 0001636282 Pharmaceutical Preparations Inc. in DE
View on SEC.gov →
Overview All Filings Annual Quarterly Insiders

Recent Filings

All 744 filings →
Form Description Date
SCHEDULE 13G/A Mar 27, 2026
EFFECT Mar 4, 2026
4 FORM 4 Mar 3, 2026
4 FORM 4 Mar 3, 2026
144 Mar 3, 2026
144 Mar 2, 2026
EFFECT Feb 27, 2026
POS AM POS AM Feb 27, 2026
S-3 S-3 Feb 19, 2026
S-8 S-8 Feb 19, 2026

Insider Transactions

View all →
Insider Title Type Shares Owns After Date
Turtle Cameron Chief Executive Officer Sale 10,995 @ $28.73 690,912 Dec 1, 2025
Turtle Cameron Chief Executive Officer Sale 16,845 @ $23.66 701,907 Nov 3, 2025
Burrows Scott L Chief Financial Officer Sale 18,428 @ $16.26 97,994 Sep 2, 2025
Albers Jeffrey W. Sale 6,700 @ $36.76 27,360 Nov 6, 2024
Albers Jeffrey W. Sale 300 @ $36.43 34,060 Oct 25, 2024
Burrows Scott L Chief Financial Officer Sale 18,531 @ $28.17 116,422 Sep 3, 2024
Turtle Cameron Chief Executive Officer Award / Grant 400 @ $9.82 746,907 Feb 15, 2024
Burrows Scott L Chief Financial Officer Award / Grant 134,953 134,953 Dec 22, 2023
Souza Marcio Purchase 90,000 @ $0.56 90,000 Aug 25, 2022
Hanley Jr. Michael Conick Chief Commercial Officer Purchase 28,200 @ $0.71 36,200 Jun 8, 2022